Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00595985 | Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | terminated | Phase 2 | 5 | Fudan UniversityOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00149266 | Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502) | terminated | Phase 3 | 167 | Japan Clinical Oncology GroupOTHER | 1 | Feb 3, 2009 | clinicaltrials |
| NCT00503321 | Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma(eNCIT-Japan) | terminated | Phase 2 / Phase 3 | 13 | Eastern Network of Cancer Immunological Therapy, JapanOTHER | 1 | Jan 23, 2009 | clinicaltrials |
| NCT00155883 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | terminated | Phase 2 | 54 | National Taiwan University HospitalOTHER | 1 | Aug 18, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Jul 7, 2009source: clinicaltrials